A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients

被引：55
|
作者：
Alvarez, RD
Curiel, DT
机构：
[1] Division of Gynecologic Oncology, Old Hillman Building, Birmingham, AL 35233-7333
[2] Gene Therapy Program, Wallace Tumor Institute, Birmingham, AL 35233-7333
来源：
HUMAN GENE THERAPY | 1997年 / 8卷 / 05期
关键词：
RETROVIRAL VECTOR; BRAIN-TUMORS; CELLS; THERAPY; CHEMOTHERAPY;
D O I：
10.1089/hum.1997.8.5-597
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：597 / 613
页数：17
相关论文
共 39 条
  • [1] Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors
    Xu, F.
    Li, S.
    Li, X-L
    Guo, Y.
    Zou, B-Y
    Xu, R.
    Liao, H.
    Zhao, H-Y
    Zhang, Y.
    Guan, Z-Z
    Zhang, L.
    CANCER GENE THERAPY, 2009, 16 (09) : 723 - 730
  • [2] Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors
    F Xu
    S Li
    X-L Li
    Y Guo
    B-Y Zou
    R Xu
    H Liao
    H-Y Zhao
    Y Zhang
    Z-Z Guan
    L Zhang
    Cancer Gene Therapy, 2009, 16 : 723 - 730
  • [3] A phase I study of recombinant adenovirus vector-mediated delivery of an Anti-erbB-2 single-chain (sFv) antibody gene for previously treated ovarian and extraovarian cancer patients
    Alvarez, RD
    Curiel, DT
    HUMAN GENE THERAPY, 1997, 8 (02) : 229 - 242
  • [4] Herpes simplex virus thymidine kinase (HSV-TK) murine vector producer cell (VPC) xenografts in women with recurrent ovarian cancer
    Link, CJ
    Moorman, DW
    Levy, J
    Tennant, L
    Edleman, M
    McDermott, J
    Galili, U
    Seregina, T
    CANCER GENE THERAPY, 1998, 5 (06) : S17 - S17
  • [5] Activation of caspase-3 noninvolved in the bystander effect of the herpes simplex virus thymidine kinase gene/ganciclovir (HSV-tk/GCV) system
    Zhang, Zhihong
    Lin, Juqiang
    Chu, Jun
    Ma, Yan
    Zeng, Shaoqun
    Luo, Qingming
    JOURNAL OF BIOMEDICAL OPTICS, 2008, 13 (03)
  • [6] Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IκBα and HSV thymidine kinase
    Moriuchi, S
    Glorioso, JC
    Maruno, M
    Izumoto, S
    Wolfe, D
    Huang, SH
    Cohen, JB
    Yoshimine, T
    CANCER GENE THERAPY, 2005, 12 (05) : 487 - 496
  • [7] Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IκBα and HSV thymidine kinase
    Shusuke Moriuchi
    Joseph C Glorioso
    Motohiko Maruno
    Shuichi Izumoto
    Darren Wolfe
    Shaohua Huang
    Justus B Cohen
    Toshiki Yoshimine
    Cancer Gene Therapy, 2005, 12 : 487 - 496
  • [8] Combination gene therapy for glioblastoma involving herpes simplex virus (HSV) vector-mediated co-delivery of mutant IκBα and HSV thymidine kinase against glioblastoma
    Moriuchi, Shusuke
    Glorioso, Joseph C.
    Maruno, Motohiko
    Izumoto, Shuichi
    Yoshimine, Toshiki
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 49 - 49
  • [9] Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase (HSV-tk) suicide gene in cancer gene therapy
    Lanuti, M
    Gao, GP
    Force, SD
    Chang, MY
    El Kouri, C
    Amin, KM
    Hughes, JV
    Wilson, JM
    Kaiser, LR
    Albelda, SM
    CANCER GENE THERAPY, 1998, 5 (06) : S8 - S9
  • [10] Phase I/II study of adenoviral vector delivery of HSV-TK gene and the intravenous administration of ganciclovir in men with local recurrence of prostate cancer after hormonal therapy
    Nasu, Y
    Ebara, S
    Kaku, H
    Saika, T
    Thompson, TC
    Kumon, H
    JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 376 - 376
1234